Background: Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT)
and pulmonary embolism (PE), occurs in∼ 1 to 2 individuals per 1000 each year …

Cancer-associated thrombosis (CAT) is a condition in which relevance has been
increasingly recognised both for physicians that deal with venous thromboembolism (VTE) …

Background The role of fibrinolytic therapy in patients with intermediate-risk pulmonary
embolism is controversial. Methods In a randomized, double-blind trial, we compared …

The task of developing ESC Guidelines covers not only the integration of the most recent
research, but also the creation of educational tools and implementation programmes for the …

Background This article addresses the treatment of VTE disease. Methods We generated
strong (Grade 1) and weak (Grade 2) recommendations based on high-quality (Grade A) …

Importance Although retrievable inferior vena cava filters are frequently used in addition to
anticoagulation in patients with acute venous thromboembolism, their benefit-risk ratio is …

Aim Thrombolytic therapy induces faster clot dissolution than anticoagulation in patients with
acute pulmonary embolism (PE) but is associated with an increased risk of haemorrhage …

Background: Despite advances in hospital management in recent years, it is not clear
whether mortality after acute pulmonary embolism (PE) has decreased over time. Objectives …

Pulmonary embolism is the third most common cause of death from cardiovascular disease
after heart attack and stroke. Sequelae occurring after venous thromboembolism include …

Methods A writing group was established with representation from the Council on Peripheral
Vascular Disease and Council on Cardiopulmonary, Critical Care, Perioperative and …